Legal issues in sharing the benefits of biodiversity prospecting

Journal of Ethnopharmacology

Volumn 51, Issue 1-3, 1996, Pages 93-109

  Mays, T D ^a   Mazan, K D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biodiversity; Contracts; Indigenous rights; Intellectual property rights

Indexed keywords

NATURAL PRODUCT;

BIODIVERSITY; CONFERENCE PAPER; ENVIRONMENTAL PROTECTION; FINANCE; LAW; NONHUMAN; POLICY; PROFIT;

EID: 0029884999     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-8741(95)01352-0     Document Type: Conference Paper

References (14)

1. M.R. Boyd National Cancer Institute drug discovery and development E.J. Frei E.J. Freireich Accomplishments in Oncology - Cancer Therapy: Where Do We Go From Here? Vol. 1 1986 J.B. Lippincott Philadelphia, PA 68 76 No. 1
2. M.R. Boyd Strategies for the identification of new agents in the treatment of AIDS: a national program to facilitate the discovery and preclinical development of V.T. DeVita S. Hellman S.A. Rosenberg AIDS: Etiology, Diagnosis, Treatment, and Prevention 1988 J.B. Lippincott Philadelphia, PA 305 317
3. M.R. Boyd Status of NCI preclinical antitumor drug discovery screen V.T. DeVita S. Hellman S.A. Rosenberg Principles and Practice of Oncology Updates Vol. 1 1989 J.B. Lippincott Philadelphia, PA 1 12 No. 1
4. M.R. Boyd The future of new drug development J. Niederhuber Current Therapy in Oncology. Section I, Introduction to Cancer Therapy 1993 BC. Decker, Inc Philadelphia, PA 11 12
5. J.D. Douros Lower plants as a source of anticancer drugs Cancer Treatment Reports 60 1976 1069 1080
6. T. Greaves Introduction T. Greaves Intellectual Property Rights For Indigenous Peoples, A Source Book 1994 Society For Applied Anthropology Oklahoma City, OK ix xii
7. W.D. Kingsbury J.C. Boehm D.R. Jakas K.H. Holden S.M. Hect G. Gallager M.J. Caragna F.L. McCabe L.F. Faucette R.K. Johnson R.P. Hertzberg Synthesis of water-soluble (aminoalkyl) camptothecin analogues: inhibition of topoisomerase I and antitumor activity Journal of Medicinal Chemistry 34 1991 98 107
8. P. O'Dwyer M. Alonso B. Leyland-Jones S. Marsoni Teniposide: a review of 12 years of experience Cancer Treatment Reports 68 1984 1455 1466
9. P. O'Dwyer M. Alonso B. Leyland-Jones S. Marsoni R. Wittes Etoposide (VP-16-213) Current status of an anticancer drug New England Journal of Medicine 312 1985 692 700
10. R. Ohno K. Okada T. Masaoka A. Kuramoto T. Arima Y. Yoshida H. Ariyashi M. Ichimaru Y. Ito Y. Morishima S. Yoomaku K. Ota An early phase study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma Journal of Clinical Oncology 8 1990 1907 1912
11. G.R. Pettit The bryostatins Fortschrift der Chemie Organische Naturst 57 1991 153 195
12. K.L. Rinehart T.G. Holt N.L. Fregeau P.A. Keifer G.R. Wilson T.J. Perun Jr. R. Sakai A.G. Thompson J.G. Stroh L.S. Shield D.S. Seigler L.H. Li D.G. Martin C.J.P. Grimmelikuhijzen G. Gade Bioactive compounds from aquatic and terrestrial sources Journal of Natural Products 53 1990 771 792
13. E.K. Rowinsky N. Onetto R.M. Canetta S.G. Arbuck Taxol: the first of the taxanes, an important new class of antitumor agents Seminars in Oncology 19 1992 646 662
14. M. Suffness J. Douros Current Status of the NCI plant and animal product program Journal of Natural Products 45 1982 1 14